QURE
Uniqure NV
NASDAQ: QURE · HEALTHCARE · BIOTECHNOLOGY
$16.73
-7.31% today
Updated 2026-04-29
Market cap
$1.05B
P/E ratio
—
P/S ratio
65.51x
EPS (TTM)
$-3.46
Dividend yield
—
52W range
$9 – $72
Volume
3.4M
Uniqure NV (QURE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $4.06M | $5.70M | $10.30M | $25.10M | $13.11M | $11.28M | $7.28M | $37.51M | $524.00M | $106.48M | $15.84M | $27.12M | $16.10M |
| Revenue growth (YoY) | — | — | — | +40.2% | +80.9% | +143.6% | -47.8% | -13.9% | -35.5% | +415.2% | +1296.8% | -79.7% | -85.1% | +71.2% | -40.6% |
| Cost of revenue | — | $13.49M | $1.10M | $43.58M | $638488.00 | $72.69M | $67.41M | $73.06M | $94.74M | $122.40M | $24.98M | $3.34M | $13.63M | $18.33M | $16.45M |
| Gross profit | — | $-13.49M | $2.96M | $-37.88M | $9.67M | $25.10M | $-54.30M | $-61.78M | $7.28M | $-84.89M | $499.03M | $103.14M | $2.21M | $8.79M | $-347000.00 |
| Gross margin | — | — | 72.8% | -664.9% | 93.8% | 100.0% | -414.3% | -547.5% | 100.0% | -226.3% | 95.2% | 96.9% | 14.0% | 32.4% | -2.2% |
| R&D | $20.09M | $13.53M | $18.20M | $41.26M | $51.15M | $72.51M | $72.38M | $74.81M | $94.74M | $122.40M | $143.55M | $197.59M | $214.86M | $143.78M | $134.43M |
| SG&A | — | $6.04M | $11.63M | $17.07M | $23.38M | $24.53M | $24.64M | $25.30M | $33.54M | $42.58M | $57.17M | $54.70M | $73.08M | $50.68M | $65.34M |
| Operating income | $-22.22M | $-18.77M | $-31.12M | $-41.14M | $-74.82M | $-71.95M | $-71.96M | $-88.23M | $-121.14M | $-125.43M | $310.62M | $-143.16M | $-282.87M | $-184.29M | $-185.47M |
| Operating margin | — | — | -765.7% | -722.2% | -726.1% | -286.7% | -549.0% | -781.9% | -1663.8% | -334.3% | 59.3% | -134.4% | -1785.5% | -679.6% | -1152.1% |
| EBITDA | $-22.63M | $-18.09M | $-33.71M | $-45.71M | $-72.48M | $-65.86M | $-69.74M | $-74.01M | $-113.72M | $-126.97M | $319.00M | $-108.02M | $-253.10M | $-160.75M | $-178.58M |
| EBITDA margin | — | — | -829.4% | -802.4% | -703.3% | -262.4% | -532.1% | -655.9% | -1561.9% | -338.5% | 60.9% | -101.4% | -1597.6% | -592.7% | -1109.3% |
| EBIT | $-23.40M | $-18.82M | $-34.45M | $-47.58M | $-77.33M | $-71.95M | $-77.28M | $-80.91M | $-120.39M | $-137.62M | $311.70M | $-116.56M | $-265.00M | $-173.39M | $-193.34M |
| Interest expense | $509364.00 | $109768.00 | $1.24M | $2.02M | $2.57M | $2.17M | $2.48M | $2.16M | $3.81M | $3.83M | $7.47M | $11.70M | $41.56M | $63.74M | $61.99M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-22.42M | $-19.46M | $-37.03M | $-45.04M | $-78.15M | $-73.37M | $-80.39M | $-83.30M | $-124.20M | $-125.02M | $329.59M | $-126.79M | $-308.48M | $-239.56M | $-198.97M |
| Net income growth (YoY) | — | +13.2% | -90.3% | -21.6% | -73.5% | +6.1% | -9.6% | -3.6% | -49.1% | -0.7% | +363.6% | -138.5% | -143.3% | +22.3% | +16.9% |
| Profit margin | — | — | -911.3% | -790.6% | -758.4% | -292.3% | -613.3% | -738.2% | -1705.8% | -333.3% | 62.9% | -119.1% | -1947.1% | -883.4% | -1236.0% |